Basilea PharmaceuticaBSLN 
$45.70-0.48%24h
-0.48%24h
Global rank10773
Market cap$548.03M
Change 7d3.26%
YTD Performance-
SP500 benchmark
P/E53.14
P/S3.13
Revenue$175.07M
Earnings$11.61M
Dividend yield-
EPS for Basilea Pharmaceutica (BSLN)
Basilea Pharmaceutica has an EPS of $0.86. In 2022, the company made an earnings per share (EPS) of $1.02. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for BSLN
-
Value:-
EPS history for Basilea Pharmaceutica from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $0.86 | -15.69% |
| 2022 | $1.02 | -275.86% |
| 2021 | -$0.58 | -59.44% |
| 2020 | -$1.43 | - |
View the highest EPS stocks
